Comparing Spectaire (NASDAQ:SPEC) & Callitas Health (OTCMKTS:MPHMF)

Spectaire (NASDAQ:SPEC) and Callitas Health (OTCMKTS:MPHMF) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, dividends and risk.

Profitability

This table compares Spectaire and Callitas Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Spectaire	N/A	-81.22%	304.57%
Callitas Health	N/A	N/A	N/A

Analyst Recommendations

This is a summary of current ratings and price targets for Spectaire and Callitas Health, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Spectaire	0	1	0	0	2.00
Callitas Health	0	0	0	0	0.00

Spectaire presently has a consensus target price of $2.50, indicating a potential upside of 4,920.08%. Given Spectaire’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Spectaire is more favorable than Callitas Health.

Volatility and Risk

Spectaire has a beta of -0.46, indicating that its share price is 146% less volatile than the S&P 500. Comparatively, Callitas Health has a beta of -3.5, indicating that its share price is 450% less volatile than the S&P 500.

Earnings & Valuation

This table compares Spectaire and Callitas Health”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Spectaire	N/A	N/A	$8.95 million	N/A	N/A
Callitas Health	$530,000.00	N/A	-$1.28 million	N/A	N/A

Spectaire has higher earnings, but lower revenue than Callitas Health.

Insider and Institutional Ownership

26.6% of Spectaire shares are owned by institutional investors. 25.4% of Spectaire shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Spectaire beats Callitas Health on 7 of the 9 factors compared between the two stocks.

About Spectaire

Spectaire Holdings Inc. provides solutions that measure, manage, and reduce carbon dioxide equivalent and other greenhouse gas emissions. The company offers AireCore, an integrated hardware, software, and data platform for logistics and supply chain players that uses mass spectrometry to directly measure their emissions. It serves the logistics, energy, agriculture, academics, and indoor air industries. The company is based in Watertown, Massachusetts.

About Callitas Health

Callitas Health, Inc. is a clinical stage company. It engages in the development of technologies for obesity, weight management, and female health and wellness. The company focuses on developing technologies for weight management, female sexual health and wellness, cannabis delivery technologies and other proprietary drugs. It launched product ToConceive in North America. The firm researches, develops and business development processes for its other OTC products, CannaMint strips and orphan drug technologies. Callitas Health was founded on March 11, 2003 and is headquartered in Newport, KY.